Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Arabidopsis thaliana was always an unlikely candidate for the limelight. But 25 years ago, the diminutive thale cress ...

Every year, the University of Kansas Cancer Center must file a report with the National Cancer Institute in order to get its ...

As we stand on the precipice of a scientific revolution, researchers are pushing the boundaries of biology by developing ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the third quarter ended September 30, 2025 and ...